Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
19 September 2014 09:28
A trial to find a vaccine against the Ebola virus is due to take place at Oxford University
A trial to find a vaccine for the deadly Ebola virus is due to begin - and a volunteer from the UK will become the first person to receive the experimental drug.
A total of 60 people are due to take part in the safety trial at the University of Oxford, which may offer hope to people in Guinea, Sierra Leone, Liberia and other West African nations where Ebola has so far killed nearly 2,500 people.
More than half of those infected with the virus (53%) have died from the disease, according to the World Health Organisation - which should serve as a reminder for people travelling to Africa to take out medical travel insurance before they depart.
The vaccine, which is part of the current trial at Oxford, has been developed by GlaxoSmithKline (GSK) and the US National Institute of Health. It is aimed at the "Zaire strand" of the virus which is among those found in West Africa.
Experts at Oxford University have emphasised that participants cannot get infected with Ebola as the drug only contains one benign protein found in the virus.
The vaccine will only be tested on healthy adults, and researchers will check for possible side-effects and the nature of the immune response. It has already been tested on animals, and early indications are that it can protect non-human primates from Ebola without significant side effects.
GSK is producing 10,000 extra doses of the vaccine while the trial takes place thanks to a £2.8 million funding boost from the Medical Research Council, the Wellcome Trust and the Department for International Development
If the Oxford trial is a success, the vaccine will be tested again in West Africa to ensure the research takes differences between populations into account.
22 September 2017
A new computer code that can be applied to GP surgery data could be the answer to identifying those most at risk of developing bowel cancer.
[more...]
21 September 2017
The World Health Organisation (WHO) has issued a warning over a growing resistance to antibiotics.
20 September 2017
Thousands of Ryanair flights have been cancelled over the next six weeks, as the airline says it "messed up" allocation of its pilots' annual leave.
19 September 2017
Manchester's Girlguides are being urged to help the elderly with a new badge incentivising youngsters to tackle senior loneliness.
16 September 2017
Holidaymakers are being evacuated as winds up to 200km per hour hit Central Vietnam, with Typhoon Doksuri damaging houses, roads and infrastructure.
15 September 2017
People in parts of East Anglia are eight times more likely to survive liver disease than Blackpool residents, according to new data by Public Health England (PHE).
14 September 2017
A non-invasive alternative to gastric bypass surgery that helps people with Type 2 diabetes lose weight is being recommended for widespread use by NHS experts.
13 September 2017
Almost half of UK adults travelling to areas at risk of malaria are not covering themselves by taking medication, despite recommendations made by the NHS and world health organisations.
12 September 2017
A new health warning has been issued by scientists in Sweden, suggesting e-cigarettes with nicotine could lead to an increased risk of heart attacks and strokes.
09 September 2017
Researchers have developed a futuristic pen-like device that can tell whether someone has cancer much faster than current technology.
08 September 2017
A staffing crisis in the NHS is seeing cancer patients turned away from their GP surgery and instead visiting A&E, a report has claimed.
07 September 2017
Whether it's binge-watching box-sets, shopping for clothes, chatting to friends or picking up work emails, staying connected is pretty much essential to everyday life.